作者: Isabelle Camby , Nathalie Nagy , Maria-Beatriz Lopes , Beat W. Schäfer , Claude-Alain Maurage
DOI: 10.1111/J.1750-3639.1999.TB00205.X
关键词:
摘要: The levels of expression the S100A1, S100A2, S100A3, S100A4, S100A5, S100A6 and S100B proteins were immunohistochemically assayed quantitatively determined in a series 95 astrocytic tumors including 26 World Health Organization (WHO) grade I (pilocytic astrocytomas), 23 WHO II (astrocytomas), 25 III (anaplastic astrocytomas) 21 IV (glioblastomas) cases. level immunohistochemical S100 was solid tumor tissue (tumor mass). In addition twenty blood vessel walls their corresponding perivascular astrocytes also for 10 cases chosen at random from each four histopathological groups. data showed modifications S100A3 protein expression; these clearly identified pilocytic astrocytomas II-IV as distinct biological group. Modifications enabled clear distinction to be made between low (WHO II) high IV) tumors. Very significant occurred S100A1 (and, lesser extent, S100A4 proteins) relation increasing malignancy. While S100A5 significantly expressed all (but without any malignancy), S100A2 never These thus indicate that several play major roles human